Title: Reliability Assessment of CT Enhancement Rate and Extracellular Volume in Liver
Fibrosis Prediction
Version: 3 Date: 15 Jan 2025
Reviewer's report:
The biggest problem is that the author confuses the liver fibrosis scoring system.
Please refer to the METAVIR scoring system as follows: no or mild liver fibrosis (no liver
fibrosis or portal fibrosis, no septum, F0-F1), moderate liver fibrosis (portal fibrosis, few septa,
F2), severe liver fibrosis (many septa, no cirrhosis, F3), cirrhosis F4.
I have made some comments and edits, see the attachment.
Please add a correlation figure to improve the readability of the paper.
Title: Reliability Assessment of CT Enhancement Rate and Extracellular Volume in Liver
Fibrosis Prediction
Version: 3 Date: 15 Jan 2025
Reviewer's report:
The biggest problem is that the author confuses the liver fibrosis scoring system.
Please refer to the METAVIR scoring system as follows: no or mild liver fibrosis (no liver
fibrosis or portal fibrosis, no septum, F0-F1), moderate liver fibrosis (portal fibrosis, few septa,
F2), severe liver fibrosis (many septa, no cirrhosis, F3), cirrhosis F4.
I have made some comments and edits, see the attachment.
Please add a correlation figure to improve the readability of the paper.
Please review this paper.
user
Title: Reliability Assessment of CT Enhancement Rate and Extracellular Volume in Liver
Fibrosis Prediction
Version: 3 Date: 15 Jan 2025
Reviewer's report:
The biggest problem is that the author confuses the liver fibrosis scoring system.
Please refer to the METAVIR scoring system as follows: no or mild liver fibrosis (no liver
fibrosis or portal fibrosis, no septum, F0-F1), moderate liver fibrosis (portal fibrosis, few septa,
F2), severe liver fibrosis (many septa, no cirrhosis, F3), cirrhosis F4.
I have made some comments and edits, see the attachment.
Please add a correlation figure to improve the readability of the paper.
assistant